Chemclin Diagnostics Co., Ltd. (688468.SS)

CNY 7.26

(0.55%)

Revenue Summary of Chemclin Diagnostics Co., Ltd.

Chemclin Diagnostics Co., Ltd.'s latest annual revenue in 2023 was 445.34 Million CNY , down -4.28% from previous year.
Chemclin Diagnostics Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 112.75 Million CNY , up 1.22% from previous quarter.
Chemclin Diagnostics Co., Ltd. reported a annual revenue of 465.27 Million CNY in annual revenue 2022, down -1.17% from previous year.
Chemclin Diagnostics Co., Ltd. reported a annual revenue of 470.77 Million CNY in annual revenue 2021, up 12.57% from previous year.
Chemclin Diagnostics Co., Ltd. reported a quarterly revenue of 112.75 Million CNY for 2024 Q2, up 1.22% from previous quarter.
Chemclin Diagnostics Co., Ltd. reported a quarterly revenue of 118.2 Million CNY for 2024 Q3, up 4.83% from previous quarter.

Annual Revenue Chart of Chemclin Diagnostics Co., Ltd. (2023 - 2017)

Historical Annual Revenue of Chemclin Diagnostics Co., Ltd. (2023 - 2017)

Year	Revenue	Revenue Growth
2023	445.34 Million CNY	-4.28%
2022	465.27 Million CNY	-1.17%
2021	470.77 Million CNY	12.57%
2020	418.2 Million CNY	-8.02%
2019	454.66 Million CNY	24.21%
2018	366.05 Million CNY	14.89%
2017	318.6 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q1	111.39 Million CNY	11.31%
2024 Q2	112.75 Million CNY	1.22%
2024 Q3	118.2 Million CNY	4.83%
2023 Q1	100.93 Million CNY	-4.2%
2023 FY	445.34 Million CNY	-4.28%
2023 Q4	100.07 Million CNY	-20.61%
2023 Q3	126.05 Million CNY	6.57%
2023 Q2	118.28 Million CNY	17.19%
2022 Q3	136.38 Million CNY	32.87%
2022 Q2	102.64 Million CNY	-15.09%
2022 Q1	120.88 Million CNY	4.83%
2022 FY	465.27 Million CNY	-1.17%
2022 Q4	105.35 Million CNY	-22.75%
2021 Q2	116.71 Million CNY	-2.91%
2021 Q1	120.21 Million CNY	-1.9%
2021 FY	470.77 Million CNY	12.57%
2021 Q4	115.31 Million CNY	-2.72%
2021 Q3	118.53 Million CNY	1.56%
2020 Q1	59.06 Million CNY	-51.47%
2020 FY	418.2 Million CNY	-8.02%
2020 Q4	122.54 Million CNY	-15.06%
2020 Q3	144.27 Million CNY	56.29%
2020 Q2	92.31 Million CNY	56.28%
2019 Q3	128.49 Million CNY	0.0%
2019 Q4	121.72 Million CNY	-5.27%
2019 FY	454.66 Million CNY	24.21%
2018 FY	366.05 Million CNY	14.89%
2017 FY	318.6 Million CNY	0.0%

Peer Revenue Comparison of Chemclin Diagnostics Co., Ltd.

Name	Revenue	Revenue Difference
Shanghai Runda Medical Technology Co., Ltd.	9.14 Billion CNY	95.131%
Joinn Laboratories(China)Co.,Ltd.	2.37 Billion CNY	81.261%
WuXi AppTec Co., Ltd.	40.04 Billion CNY	98.888%
Autobio Diagnostics Co., Ltd.	4.44 Billion CNY	89.978%
Thalys Medical Technology Group Inc.	2 Billion CNY	77.801%
Guangzhou Kingmed Diagnostics Group Co., Ltd.	8.53 Billion CNY	94.785%